Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Wimbauer, Fritz ^a,b   Yang, Caihong ^a,c   Shogren, Kristen L ^a   Zhang, Minzhi ^a   Goyal, Ribu ^a   Riester, Scott M ^a   Yaszemski, Michael J ^a,b   Maran, Avudaiappan ^a,b  

^a Mayo Clinic   (United States)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

2 methoxyestradiol; GAS; Interferon; ISRE; Osteosarcoma

Indexed keywords

ESTRADIOL 3 METHYL ETHER; INITIATION FACTOR 2ALPHA; INTERFERON; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA STRUCTURE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON GENE; OSTEOBLAST; OSTEOSARCOMA CELL; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

BONE NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERONS; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84858312636     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-93     Document Type: Article

References (31)

1. O'Reilly R, Cheung NK, Bowman L, Castle V, Hoffer F, Kapoor N, Kletzel M, Lindsley K, Shamberger R, Tubergen D. NCCN pediatric neuroblastoma practice guidelines. The National Comprehensive Cancer Network. Oncology (Huntingt) 1996, 10(12):1813-1822.
2. Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, Eilber FR, Eckardt JJ. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994, 12(9):1849-1858.
3. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994, 368(6468):237-239. 10.1038/368237a0, 7511798.
4. Benedikt MB, Mahlum EW, Shogren KL, Subramaniam M, Spelsberg TC, Yaszemski MJ, Maran A. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. JCellBiochm 2010, 109(5):950-956.
5. Maran A, Zhang M, Kennedy AM, Sibonga JD, Rickard DJ, Spelsberg TC, Turner RT. 2-Methoxyestradiol Induces Interferon Gene Expression and Apoptosis in Osteosarcoma Cells. BONE 2002, 30(2):393-398. 10.1016/S8756-3282(01)00681-0, 11856647.
6. Pribluda VS, Gubish ER, Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Met Rev 2000, 19(1-2):173-179.
7. Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM, Waes C. 2-Methoxyestradiol Inhibits Hypoxia-Inducible Fator 1a, Tumor Growth, and Angigenesis and Augements Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2004, 10:8665-8673. 10.1158/1078-0432.CCR-04-1393, 15623651.
8. Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T. Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 1999, 5(3):493-499.
9. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Ann Rev Biochem 1998, 67:227-264. 10.1146/annurev.biochem.67.1.227, 9759489.
10. Strander H. Interferons and osteosarcoma. Cytokine & Growth Factor Rev 2007, 18(5-6):373-380. 10.1016/j.cytogfr.2007.06.014, 3317641, 22485186.
11. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003, 8(3):237-249. 10.1023/A:1023668705040, 12766484.
12. Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. The role of interferons in the treatment of osteosarcoma. Pediatr Blood Cancer 2010, 54(3):350-354. 10.1002/pbc.22136, 19902521.
13. Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. International orthopaedics 2006, 30(6):445-451. 10.1007/s00264-006-0192-x, 3172747, 16896870.
14. Glasgow LA, Kern ER. Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model. Journal of the National Cancer Institute 1981, 67(1):207-212.
15. Jia SF, An T, Worth L, Kleinerman ES. Interferon-alpha enhances the sensitivity of human osteosarcoma cells to etoposide. J Interferon Cytokine Res 1999, 19(6):617-624. 10.1089/107999099313758, 10433362.
16. Jia SF, Kleinerman ES. Antitumor activity of TNF-alpha, IL-1, and IFN-gamma against three human osteosarcoma cell lines. Lymphokine Cytokine Res 1991, 10(4):281-284.
17. Robey PG, Termine JD. Human bone cells in vitro. Calcified tissue international 1985, 37(5):453-460. 10.1007/BF02557826, 2998572.
18. Shogren KL, Turner RT, Yaszemski MJ, Maran A. Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells. J Bone Miner Res 2007, 22(1):29-36. 1955766, 17014383.
19. Maran A, Shogren KL, Benedikt M, Sarkar G, Turner RT, Yaszemski MJ. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest. JCellBiochm 2008, 104:1937-1945.
20. Wesoly J, Szweykowska-Kulinska Z, Bluyssen HA. STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim Pol 2007, 54(1):27-38.
21. Tsukahara T, Kim S, Taylor MW. REFINEMENT: a search framework for the identification of interferon-responsive elements in DNA sequences-a case study with ISRE and GAS. Comput Biol Chem 2006, 30(2):134-147. 10.1016/j.compbiolchem.2006.01.002, 16546448.
22. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 1994, 76(5):821-828. 10.1016/0092-8674(94)90357-3, 7510216.
23. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 1997, 17(3):121-134. 10.1089/jir.1997.17.121, 9085936.
24. Sikorski K, Chmielewski S, Przybyl L, Heemann U, Wesoly J, Baumann M, Bluyssen HA. STAT1-mediated signal integration between IFNgamma and LPS leads to increased EC and SMC activation and monocyte adhesion. Am J Physiol Cell Physiol 2011, 300(6):C1337-1344. 10.1152/ajpcell.00276.2010, 21346151.
25. Yuan XW, Zhu XF, Huang XF, Sheng PY, He AS, Yang ZB, Deng R, Feng GK, Liao WM. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis. Acta Pharmacol Sin 2007, 28(11):1835-1841. 10.1111/j.1745-7254.2007.00662.x, 17959036.
26. Balachandran S, Barber GN. PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol 2007, 383:277-301. 10.1007/978-1-59745-335-6_18, 18217692.
27. Clemens MJ. Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene 2004, 23(18):3180-3188. 10.1038/sj.onc.1207544, 15094767.
28. Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006, 34(Pt 1):7-11.
29. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005, 6(4):318-327. 10.1038/nrm1618, 15803138.
30. Gale M, Tan SL, Katze MG. Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 2000, 64(2):239-280. 10.1128/MMBR.64.2.239-280.2000, 98994, 10839817.
31. Kubo T, Shimose S, Matsuo T, Fujimori J, Arihiro K, Ochi M. Interferon-alpha/beta receptor as a prognostic marker in osteosarcoma. J Bone Joint Surg Am 2011, 93(6):519-526. 10.2106/JBJS.J.00198, 21411701.